Skip to main content
Research project

Niraparib Efficacy in Relapsed MesOthelioma (NERO). A Randomised Phase II trial of Niraparib versus active symptom control in Patients with Relapsed Malignant Mesothelioma

Lead researcher:
Research funder:
British Lung Foundation
Status:
Active
Back to top